Vydra Jan

32PUBLICATIONS
129CO-AUTHORS
Predictive and prognostic markersTransplantation immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Oct 07, 2026
Choice of a different donor reduces relapse risk after second allogeneic SCT for MDS.

|Sep 30, 2026
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome in young adults: A retrospective study on behalf of the EBMT Chronic Malignancies Working Party.

|Sep 10, 2026
Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party.

|Jul 13, 2026
Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

|Jun 29, 2026
T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT.

|Mar 26, 2026
Peripheral blood stem cells versus bone marrow graft for non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT.

Arnon Nagler, Ryszard Swoboda, Allain-Thibeault Ferhat

Pageof 6

Frequent Collaborators

16 joint publications

Arnon Nagler

16 joint publications

Mohamad Mohty

13 joint publications

Alexander Kulagin

13 joint publications

Fabio Ciceri